{"id":"https://openalex.org/W2921038102","doi":"https://doi.org/10.1111/dom.13694","title":"Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes","display_name":"Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes","publication_year":2019,"publication_date":"2019-03-08","ids":{"openalex":"https://openalex.org/W2921038102","doi":"https://doi.org/10.1111/dom.13694","mag":"2921038102","pmid":"https://pubmed.ncbi.nlm.nih.gov/30848039","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6618330"},"language":"en","primary_location":{"id":"doi:10.1111/dom.13694","doi":"https://doi.org/10.1111/dom.13694","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13694","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13694","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13694","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100655031","display_name":"Kibum Kim","orcid":"https://orcid.org/0000-0002-8676-7434","observed_orcids":["https://orcid.org/0000-0002-8676-7434"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kibum Kim","raw_affiliation_strings":["Pharmacotherapy Outcomes Research Center and Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacotherapy Outcomes Research Center and Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008738856","display_name":"Sudhir K. Unni","orcid":"https://orcid.org/0000-0002-0667-6277","observed_orcids":["https://orcid.org/0000-0002-0667-6277"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudhir Unni","raw_affiliation_strings":["Pharmacotherapy Outcomes Research Center and Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacotherapy Outcomes Research Center and Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040963321","display_name":"Diana I Brixner","orcid":"https://orcid.org/0000-0001-6637-6359","observed_orcids":["https://orcid.org/0000-0001-6637-6359"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana I. Brixner","raw_affiliation_strings":["Pharmacotherapy Outcomes Research Center and Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacotherapy Outcomes Research Center and Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sheila M. Thomas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheila M. Thomas","raw_affiliation_strings":["Global Health Economics and Value Assessment, Sanofi Inc., Bridgewater, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Economics and Value Assessment, Sanofi Inc., Bridgewater, New Jersey","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056145391","display_name":"Cody J. Olsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cody J. Olsen","raw_affiliation_strings":["Pharmacy Services, Select Health, Murray, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Services, Select Health, Murray, Utah","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101609219","display_name":"Kimberly L. Sterling","orcid":"https://orcid.org/0000-0002-6482-3562","observed_orcids":["https://orcid.org/0000-0002-6482-3562"]},"institutions":[{"id":"https://openalex.org/I4210111804","display_name":"Sanofi (United States)","ror":"https://ror.org/027vj4x92","country_code":"US","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210111804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly L. Sterling","raw_affiliation_strings":["Global Health Economics and Value Assessment, Sanofi Inc., Bridgewater, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Health Economics and Value Assessment, Sanofi Inc., Bridgewater, New Jersey","institution_ids":["https://openalex.org/I4210111804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071682905","display_name":"Matt Mitchell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Mitchell","raw_affiliation_strings":["Pharmacy Services, Select Health, Murray, Utah"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Services, Select Health, Murray, Utah","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075037733","display_name":"Carrie McAdam\u2010Marx","orcid":"https://orcid.org/0000-0002-7315-6896","observed_orcids":["https://orcid.org/0000-0002-7315-6896"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Carrie McAdam\u2010Marx","raw_affiliation_strings":["Pharmaceutical Evaluation and Policy Division, University of Arkansas for Medical Sciences, Little Rock, Arkansas","Pharmacotherapy Outcomes Research Center and Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah"],"raw_orcid":"https://orcid.org/0000-0002-7315-6896","affiliations":[{"raw_affiliation_string":"Pharmaceutical Evaluation and Policy Division, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]},{"raw_affiliation_string":"Pharmacotherapy Outcomes Research Center and Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah","institution_ids":["https://openalex.org/I223532165"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5075037733"],"corresponding_institution_ids":["https://openalex.org/I223532165","https://openalex.org/I79620101"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":0.5271,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.70938248,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"21","issue":"7","first_page":"1725","last_page":"1733"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9110000133514404},{"id":"https://openalex.org/keywords/hba1c-trajectories","display_name":"HbA1c trajectories","score":0.871999979019165},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9679999947547913},{"id":"https://openalex.org/keywords/treatment-intensification","display_name":"treatment intensification","score":0.9309999942779541},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.8849999904632568},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.7940000295639038},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9679999947547913},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8230000138282776},{"id":"https://openalex.org/keywords/inadequate-glycemic-control","display_name":"inadequate glycemic control","score":0.6200000047683716},{"id":"https://openalex.org/keywords/health-insurance-claims","display_name":"health insurance claims","score":0.5669999718666077},{"id":"https://openalex.org/keywords/mixed-effects-regression","display_name":"mixed-effects regression","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8093676567077637},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6826668977737427},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6319206357002258},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6189545392990112},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5813467502593994},{"id":"https://openalex.org/C2909938374","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated haemoglobin","level":4,"score":0.4961727559566498},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4439886212348938},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4373134970664978},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.43565064668655396},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.43117713928222656},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.42972803115844727},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4126133620738983}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/dom.13694","doi":"https://doi.org/10.1111/dom.13694","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13694","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13694","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:30848039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30848039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6618330","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6618330/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/dom.13694","doi":"https://doi.org/10.1111/dom.13694","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13694","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13694","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320310050","display_name":"University of Utah","ror":"https://ror.org/03r0ha626"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2921038102.pdf","grobid_xml":"https://content.openalex.org/works/W2921038102.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W7817381","https://openalex.org/W126610468","https://openalex.org/W1965751712","https://openalex.org/W2067650081","https://openalex.org/W2088241760","https://openalex.org/W2115179266","https://openalex.org/W2123946565","https://openalex.org/W2124234371","https://openalex.org/W2126946832","https://openalex.org/W2128050336","https://openalex.org/W2366221926","https://openalex.org/W2500897968","https://openalex.org/W2507901651","https://openalex.org/W2519163037","https://openalex.org/W2587123963","https://openalex.org/W2590838134","https://openalex.org/W2596628443","https://openalex.org/W2623276389","https://openalex.org/W2739699420","https://openalex.org/W2756376910","https://openalex.org/W2916996193","https://openalex.org/W4256525495"],"related_works":["https://openalex.org/W2808829632","https://openalex.org/W2587123963","https://openalex.org/W2911573799","https://openalex.org/W2918932433","https://openalex.org/W2979264762","https://openalex.org/W2909945733","https://openalex.org/W2931442673","https://openalex.org/W4414569501","https://openalex.org/W2366221926","https://openalex.org/W4416853928"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"identify":[2],"change":[3,173],"in":[4,14,132,139,158,176,241],"glycated":[5],"haemoglobin":[6],"(HbA1c)":[7],"for":[8,46,94],"1":[9,95],"year":[10,96],"after":[11,97],"treatment":[12,63,119,204],"intensification":[13,98,120,203,223],"patients":[15,111,159,169,220],"with":[16,57,66,112,160,221,237,246,260],"HbA1c":[17,82,92,117,129,148,162,177,189,206,212,226,252,255,265],">53":[18],"mmol/mol":[19,84,125,180,183,216,229,269],"(7.0%)":[20,85,230],"while":[21,231],"on":[22,86,202,210,232],"two":[23,87,233],"classes":[24],"of":[25,80,121,178],"oral":[26],"antidiabetic":[27],"drugs":[28],"(OADs).":[29],"MATERIAL":[30],"AND":[31],"METHODS:":[32],"A":[33],"retrospective":[34],"cohort":[35],"study":[36],"was":[37,64,99,130,146,235],"conducted":[38],"using":[39,101],"a":[40,68,74,102,113,238,249,261],"regional":[41],"health":[42],"plan":[43],"claims":[44],"database":[45],"the":[47,133,140,147,154,192],"period":[48],"January":[49],"1,":[50],"2010":[51],"to":[52,190,196,275,279],"March":[53],"31,":[54],"2017.":[55],"Patients":[56,244],"type":[58],"2":[59],"diabetes":[60],"(T2DM)":[61],"whose":[62],"intensified":[65,245,259],"insulin,":[67],"glucagon-like":[69],"peptide-1":[70],"receptor":[71],"agonist":[72],"or":[73],"third":[75],"OAD":[76],"within":[77],"365":[78],"days":[79],"having":[81],"\u226553":[83,228],"OADs":[88,234],"were":[89],"included.":[90],"The":[91,107,186],"trajectory":[93],"estimated":[100],"mixed-effects":[103],"regression":[104],"model.":[105],"RESULTS:":[106],"analysis":[108,187],"included":[109],"1226":[110],"mean":[114],"\u00b1":[115,123,127],"SD":[116],"at":[118,194,207],"74.2":[122],"18.7":[124],"(8.93":[126],"1.7%).":[128],"higher":[131,250],"insulin":[134,247],"group":[135,142],"(74.2":[136],"mmol/mol)":[137],"than":[138,257],"non-insulin":[141,262],"(70.6":[143],"mmol/mol),":[144],"as":[145],"decrease":[149],"(P":[150],"<":[151],"0.01)":[152],"over":[153],"1-year":[155],"follow-up,":[156],"particularly":[157],"baseline":[161,251],">9%.":[163],"After":[164],"intensification,":[165,200],"insulin-":[166],"and":[167,181,205],"non-insulin-treated":[168],"achieved":[170],"an":[171,225],"average":[172],"by":[174],"month":[175],"-4.7":[179],"-2.6":[182],"points,":[184],"respectively.":[185],"predicted":[188],"be":[191],"lowest":[193],"6":[195],"10":[197],"months":[198],"post":[199],"depending":[201],"intensification;":[208],"however,":[209],"average,":[211],"remained":[213,266],"above":[214,267],"64.0":[215],"(8.0%).":[217],"CONCLUSION:":[218],"In":[219],"T2DM,":[222],"following":[224],"value":[227],"associated":[236],"significant":[239],"improvement":[240],"glycaemic":[242,281],"control.":[243,282],"had":[248],"but":[253],"greater":[254],"reduction":[256],"those":[258],"agent.":[263],"However,":[264],"64":[268],"(8.0%)":[270],"overall.":[271],"Additional":[272],"opportunity":[273],"exists":[274],"further":[276],"intensify":[277],"therapy":[278],"improve":[280]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-03-22T00:00:00"}